Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 1 3Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 3Unknown 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Other solid neoplasm 1

Conditions

Breast Neoplasms 2Solid Tumors 1Inflammation 1Heart Failure 1

Interventions

pembrolizumab 219Carboplatin 218Specimen Handling 198Cisplatin 188Magnetic Resonance Spectroscopy 168Radiotherapy 152Bevacizumab 142Gemcitabine 135Cyclophosphamide 133Drug Therapy 118Capecitabine 118Paclitaxel 112Oxaliplatin 110Biopsy 107venetoclax 102Nivolumab 101Rituximab 83tislelizumab 81durvalumab 81toripalimab 77Fluorouracil 73Etoposide 72Dexamethasone 70sintilimab 67Radiosurgery 67Docetaxel 67Pemetrexed 65atezolizumab 64Azacitidine 63Injections 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × dapagliflozin × Clear all
NCT06427226 2026-04-17

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

Tanta University

Phase 2 Recruiting
46 enrolled
Breast

Breast Neoplasms

NCT07018622 2026-03-11

DAPA-ARMOR

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Phase 2 Recruiting
46 enrolled
Other solid neoplasm

Solid Tumors

NCT07245069 2025-11-24

Alpaca

University Medical Centre Ljubljana

Phase 2 Recruiting
100 enrolled
Breast

Breast Neoplasms, Heart Failure, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡